Expertise in
1
conditions

Timothy Chimunda

Grattan Street, 
Parkville, VIC, AU 
Expertise in
1
conditions
Grattan Street, 
Parkville, VIC, AU 

Overview

Timothy Chimunda practices practicing medicine in Parkville, Australia.

Mr. Chimunda is highly rated in 1 condition, according to our data. His clinical expertise encompasses Swallowing Difficulty, Necrotizing Fasciitis, Status Epilepticus, and Meningitis.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Grattan Street, Parkville, VIC 3010, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
Enrollment Status: Completed
Publish Date: December 12, 2023
Intervention Type: Other
Study Phase: Not Applicable
Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults
Comparison of Plasmalyte 148® and Saline for Fluid Resuscitation and Intravenous Fluid Therapy in Critically Ill Adults
Enrollment Status: Completed
Publish Date: August 08, 2023
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

12 Total Publications

Exploring explainable machine learning techniques to aid dysphagia risk identification: A feasibility study.
Exploring explainable machine learning techniques to aid dysphagia risk identification: A feasibility study.
Journal: Australian critical care : official journal of the Confederation of Australian Critical Care Nurses
Published: December 01, 2024

Frequently Asked Questions about Timothy Chimunda

Is Timothy Chimunda a top-rated expert for Swallowing Difficulty?

MediFind is an objective health platform that identifies experts based on real-world data. Timothy Chimunda is classified as an Advanced expert for Swallowing Difficulty, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Timothy Chimunda participate in research or clinical trials?

Yes. Timothy Chimunda has published 12 articles and abstracts on conditions like Swallowing Difficulty. You can view a list of Timothy Chimunda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chimunda's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile